GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bionet 1784.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

46.50

+1.31%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.24bn

FY2016FY2025

Net income

TWD 51.4m

FY2016FY2025

Free cash flow

TWD 15.9m

FY2016FY2025

Shareholders' equity

TWD 1.27bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.24bnTWD 1.22bnTWD 1.13bnTWD 980.4mTWD 921.4mTWD 806.6mTWD 775.6mTWD 770.6mTWD 697.4mTWD 678.7m
Gross profitTWD 683.9mTWD 685.8mTWD 638.3mTWD 542.2mTWD 503.1mTWD 412.0mTWD 421.5mTWD 443.0mTWD 366.2mTWD 335.7m
Research and developmentTWD 150.8mTWD 139.0mTWD 118.8mTWD 90.3mTWD 85.6mTWD 52.4mTWD 46.8mTWD 43.0mTWD 38.7mTWD 37.6m
Operating income−TWD 12.1mTWD 63.0mTWD 109.1mTWD 74.0mTWD 41.9mTWD 7.6mTWD 8.8mTWD 34.2m−TWD 2.8m−TWD 24.3m
Net incomeTWD 51.4mTWD 83.7mTWD 78.4mTWD 38.0mTWD 26.6mTWD 12.7mTWD 6.8mTWD 24.2m−TWD 6.3m−TWD 9.4m
Diluted earnings per share1.021.741.660.810.560.270.140.50-0.13-0.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.08bnTWD 3.16bnTWD 2.35bnTWD 1.84bnTWD 1.78bnTWD 1.73bnTWD 1.76bnTWD 1.78bnTWD 1.82bnTWD 1.87bn
Cash and short-term investments——TWD 907.4mTWD 438.8mTWD 385.1mTWD 390.0m———TWD 515.0m
Total liabilitiesTWD 822.6mTWD 760.4mTWD 626.5mTWD 514.0mTWD 468.2mTWD 445.4mTWD 453.9mTWD 443.1mTWD 453.3mTWD 744.4m
Debt—TWD 94.3mTWD 42.9mTWD 13.0mTWD 13.3mTWD 12.8mTWD 13.4m———
Shareholders' equityTWD 1.27bnTWD 1.33bnTWD 1.19bnTWD 1.08bnTWD 1.10bnTWD 1.08bnTWD 1.07bnTWD 1.10bnTWD 1.12bnTWD 1.13bn
Shares outstanding50m48m47m47m48m48m47m48m50m49m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 148.0mTWD 176.5mTWD 153.1mTWD 94.7mTWD 13.9mTWD 73.7mTWD 2.7m−TWD 13.0m−TWD 24.9m−TWD 13.8m
Capital spending−TWD 132.2m−TWD 103.5m−TWD 26.3m−TWD 32.9m−TWD 16.7m−TWD 38.0m−TWD 11.6m−TWD 16.6m−TWD 10.0m−TWD 21.2m
Free cash flowTWD 15.9mTWD 73.0mTWD 126.8mTWD 61.7m−TWD 2.8mTWD 35.6m−TWD 8.9m−TWD 29.6m−TWD 34.9m−TWD 35.1m
Dividends paid−TWD 70.1m−TWD 33.2m−TWD 32.6m−TWD 23.5m−TWD 8.8m−TWD 18.3m−TWD 13.3m−TWD 13.3m−TWD 13.3m−TWD 20.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 338.4mTWD 314.7mTWD 343.4mTWD 298.0mTWD 304.4mTWD 290.8mTWD 328.9mTWD 303.9m
Gross profitTWD 195.1mTWD 169.3mTWD 194.1mTWD 163.8mTWD 168.5mTWD 157.4mTWD 191.0mTWD 171.1m
Operating incomeTWD 7.4m−TWD 3.3m−TWD 2.9m−TWD 12.7mTWD 1.8mTWD 1.7mTWD 13.5mTWD 9.0m
Net incomeTWD 19.8mTWD 12.4mTWD 14.7mTWD 10.3mTWD 11.4mTWD 15.0mTWD 33.1mTWD 11.6m
Diluted earnings per share0.400.250.290.200.230.300.690.24
Cash from operationsTWD 51.0mTWD 3.0mTWD 28.0mTWD 85.0mTWD 71.0m−TWD 37.0mTWD 59.0mTWD 69.0m
Capital spending−TWD 10.0m−TWD 13.0m−TWD 38.0m−TWD 42.0m−TWD 20.0m−TWD 30.0m−TWD 19.0m−TWD 33.0m
Free cash flowTWD 41.0m−TWD 10.0m−TWD 10.0mTWD 43.0mTWD 51.0m−TWD 67.0mTWD 40.0mTWD 36.0m
Total assetsTWD 3.08bnTWD 3.10bnTWD 3.08bnTWD 3.10bnTWD 3.08bnTWD 3.14bnTWD 3.16bnTWD 2.92bn
Shareholders' equityTWD 1.23bnTWD 1.24bnTWD 1.27bnTWD 1.26bnTWD 1.26bnTWD 1.26bnTWD 1.33bnTWD 1.25bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin55.3%56.1%56.6%55.3%54.6%51.1%
Operating margin1.7%8.5%9.7%7.6%4.5%0.9%
Net margin4.2%6.8%7.0%3.9%2.9%1.6%
Return on equity4.0%6.3%6.6%3.5%2.4%1.2%
Return on assets1.7%2.7%3.3%2.1%1.5%0.7%
Free cash flow yield—10.3%6.7%4.8%1.1%4.1%
Revenue growth1.2%8.4%15.0%6.4%14.2%4.0%
Earnings growth-38.6%6.8%106.5%42.6%109.0%87.3%
Current ratio4.62x5.06x3.90x3.06x2.77x3.40x
Debt to equity——0.03x0.01x0.01x0.02x
Equity ratio41.3%42.3%50.6%58.8%61.5%62.1%
Interest coverage13.84x80.94x266.09x161.67x107.73x22.99x
R&D as a share of sales12.2%11.4%10.5%9.2%9.3%6.5%
Buybacks as a share of market value—-1.6%-0.7%1.7%-0.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.0%8.9%7.1%
Operating income——22.1%
Net income10.6%32.2%8.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.7%55.8%55.1%54.7%
Operating margin2.1%5.1%4.5%3.0%
Net margin5.5%5.5%4.6%3.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings101.345.631.548.863.8135.8254.347.0-192.1-142.7
Price to sales4.23.12.21.91.82.12.21.51.72.0

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 3 Oct 2025.

FY2025FY2024FY2023FY2022
Paid in the year1.4160.7090.6260.437
  • 1070.9238-for-1000 split · 19 Sept 2024
  • 1020.89-for-1000 split · 23 Sept 2010
  • 103.151-for-100 split · 25 Aug 2009
  • 100.989-for-100 split · 25 Aug 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.